Helio Health is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw.
Helio Health has raised $118.0M in total funding. The most recent round was Series B. The last funding was announced in July 2021.
Helio Health's investors include Fulgent Therapeutics, Samsung Securities.
Helio Health is headquartered in Irvine, United States.
Helio Health is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw.
Helio Health is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helio Health — Funding & Investors." VCBacked, July 15, 2021, https://www.vcbacked.co/company/helio-health. Accessed September 6, 2026.
VCBacked. (2021). Helio Health — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/helio-health
{{cite web |title=Helio Health — Funding & Investors |url=https://www.vcbacked.co/company/helio-health |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated